Page 28 - Bharat Biotech

With no Aug 15 deadline, Covaxin clinical trial timelines get site-specific

Sites may end with varying timeline based on site initiation visit by Bharat Biotech

ICMR's deadline for Covid-19 vaccine launch an 'unscientific gaffe': Sibal

Bharat Biotech had recently received a nod for a clinical trial of its vaccine - Covaxin

Covaxin, ZyCov-D trails mark 'beginning of the end' of Covid-19: Scientist

The article has been published on the websites of the Press Information Bureau (PIB) and the Vigyan Prasar, which is a body under the ministry

Human trial stage of vaccine 'marks beginning of the end' of Covid-19: Govt

Along with the two Indian efforts, the world over, 11 out of 140 vaccine candidates have entered the human trial phase

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

ICMR-Bharat Biotech Covid-19 vaccine trial results to be released by Aug 15

A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government

Nearly 21,000 cases in a day in India: Coronavirus updates and highlights

India reported nearly 21,000 coronavirus cases in the last 24 hours, taking the total to 625,544, according to the Health Ministry.

Covid-19 crisis: Health care workers may get vaccine after phase 2 trials

Indigenously developed Bharat Biotech's vaccine candidate Covaxin is entering human trials on Wednesday.

Covid-19 crisis: Bharat Biotech's vaccine gets nod for human trials

The SARS-CoV-2 strain was isolated at National Institute of Virology (Pune), an institute under the ICMR, and transferred to Bharat Biotech.

Shot of Hope: Equal access a hurdle after race to coronavirus vaccine

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created

CEPI to grant $14 mn for trial of Bharat Biotech's Chikungunya vaccine

The vaccine completed standard pre-clinical studies, and an optimum immune response was elicited by the adjuvant vaccine in phase-1 trials in India

Covid-19 vaccine development moving positively, says Bharat Biotech CEO

He expressed satisfaction on the progress of the research connected with the vaccine development so far, but insisted that "in science, things can change"

Bharat Biotech working on Covid-19 vaccine using dormant rabies inoculation

Ties up with Thomas Jefferson University to develop a vaccine candidate that showed a strong antibody response in mice

India coronavirus dispatch: The search for a cure, and India's response

From the SARS-CoV-2 strain in India, to migrant workers in this lockdown, and whether ultraviolet light can help detect and kill coronavirus - read these and more in today's India dispatch

ICMR teams up with Bharat Biotech Limited to develop coronavirus vaccine

The vaccine will be developed using the virus strain isolated at the ICMR's National Institute of Virology (NIV), Pune, a statement said.

Not just bigwigs, Mid-rung local players join coronavirus vaccine race

With vaccines of some firms already in animal trial phase, developers say that if all goes well, India could have a vaccine by next year

Bharat Biotech joins global efforts in developing coronavirus vaccine

CoroFlu will build on the backbone of vaccine firm FluGen's flu vaccine candidate, a self-limiting version of the influenza virus that induces an immune response against the flu.

Bharat Biotech to collaborate with Hilleman to develop cholera vaccine

Hillchol was designed at the University of Gothenburg in Sweden and subsequently developed by Hilleman Labs

Bharat Biotech to acquire GSK's Indian vaccine firm for undisclosed sum

Target company is a single-product vaccine maker with an installed capacity of 15 million doses of anti-rabies vaccine a year; revenues were Rs 180 cr last year

Bharat Biotech's typhoid vaccine gets WHO pre-qualification

Typbar TCV is a result of dedicated product development at Bharat Biotech since 2001